344 related articles for article (PubMed ID: 36926701)
1. Inducing prion protein shedding as a neuroprotective and regenerative approach in pathological conditions of the brain: from theory to facts.
Matamoros-Angles A; Mohammadi B; Song F; Shafiq M; Brenna S; Puig B; Glatzel M; Altmeppen HC
Neural Regen Res; 2023 Sep; 18(9):1869-1875. PubMed ID: 36926701
[TBL] [Abstract][Full Text] [Related]
2. Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein.
Mohammadi B; Song F; Matamoros-Angles A; Shafiq M; Damme M; Puig B; Glatzel M; Altmeppen HC
Cell Tissue Res; 2023 Apr; 392(1):215-234. PubMed ID: 35084572
[TBL] [Abstract][Full Text] [Related]
3. Proteostasis unbalance in prion diseases: Mechanisms of neurodegeneration and therapeutic targets.
Thellung S; Corsaro A; Dellacasagrande I; Nizzari M; Zambito M; Florio T
Front Neurosci; 2022; 16():966019. PubMed ID: 36148145
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
5. Molecular dynamics studies on the buffalo prion protein.
Zhang J; Wang F; Chatterjee S
J Biomol Struct Dyn; 2016; 34(4):762-77. PubMed ID: 26043781
[TBL] [Abstract][Full Text] [Related]
6. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
Moreno JA; Telling GC
Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
[TBL] [Abstract][Full Text] [Related]
7. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
8. Molecular dynamics studies on the NMR and X-ray structures of rabbit prion proteins.
Zhang J; Zhang Y
J Theor Biol; 2014 Feb; 342():70-82. PubMed ID: 24184221
[TBL] [Abstract][Full Text] [Related]
9. [Biology of non-conventional transmissible agents or prions].
Dormont D
Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
[TBL] [Abstract][Full Text] [Related]
10.
Meyerett-Reid C; Wyckoff AC; Spraker T; Pulford B; Bender H; Zabel MD
mSphere; 2017; 2(1):. PubMed ID: 28144628
[TBL] [Abstract][Full Text] [Related]
11. Seeded fibrillation as molecular basis of the species barrier in human prion diseases.
Luers L; Bannach O; Stöhr J; Wördehoff MM; Wolff M; Nagel-Steger L; Riesner D; Willbold D; Birkmann E
PLoS One; 2013; 8(8):e72623. PubMed ID: 23977331
[TBL] [Abstract][Full Text] [Related]
12. Generating Bona Fide Mammalian Prions with Internal Deletions.
Munoz-Montesino C; Sizun C; Moudjou M; Herzog L; Reine F; Chapuis J; Ciric D; Igel-Egalon A; Laude H; Béringue V; Rezaei H; Dron M
J Virol; 2016 Aug; 90(15):6963-6975. PubMed ID: 27226369
[TBL] [Abstract][Full Text] [Related]
13. Chronic wasting disease of elk and deer and Creutzfeldt-Jakob disease: comparative analysis of the scrapie prion protein.
Xie Z; O'Rourke KI; Dong Z; Jenny AL; Langenberg JA; Belay ED; Schonberger LB; Petersen RB; Zou W; Kong Q; Gambetti P; Chen SG
J Biol Chem; 2006 Feb; 281(7):4199-206. PubMed ID: 16338930
[TBL] [Abstract][Full Text] [Related]
14. [Prion diseases or transmissible spongiform encephalopathies].
Brandel JP
Rev Med Interne; 2022 Feb; 43(2):106-115. PubMed ID: 34148672
[TBL] [Abstract][Full Text] [Related]
15. Structural and mechanistic aspects influencing the ADAM10-mediated shedding of the prion protein.
Linsenmeier L; Mohammadi B; Wetzel S; Puig B; Jackson WS; Hartmann A; Uchiyama K; Sakaguchi S; Endres K; Tatzelt J; Saftig P; Glatzel M; Altmeppen HC
Mol Neurodegener; 2018 Apr; 13(1):18. PubMed ID: 29625583
[TBL] [Abstract][Full Text] [Related]
16.
Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
[TBL] [Abstract][Full Text] [Related]
17. Protein Misfolding Cyclic Amplification of Infectious Prions.
Moda F
Prog Mol Biol Transl Sci; 2017; 150():361-374. PubMed ID: 28838669
[TBL] [Abstract][Full Text] [Related]
18. Prion protein self-interactions: a gateway to novel therapeutic strategies?
Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
[TBL] [Abstract][Full Text] [Related]
19. Prion encephalopathies of animals and humans.
Prusiner SB
Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
[TBL] [Abstract][Full Text] [Related]
20. Iron in neurodegenerative disorders of protein misfolding: a case of prion disorders and Parkinson's disease.
Singh N; Haldar S; Tripathi AK; McElwee MK; Horback K; Beserra A
Antioxid Redox Signal; 2014 Jul; 21(3):471-84. PubMed ID: 24512387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]